Yu Yang, Yamauchi Suguru, Yoshimoto Yutaro, Yube Yukinori, Kaji Sanae, Fukunaga Tetsu
Department of Esophageal and Gastroenterological Surgery, Faculty of Medicine, Juntendo University, 3-1-3, Hongo, Bunkyo-ku, Tokyo, 113-8431, Japan.
Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, No. 52 Fucheng Rd, Haidian District, Beijing, 100142, China.
J Robot Surg. 2025 May 4;19(1):196. doi: 10.1007/s11701-025-02347-9.
No studies have compared the efficacy of laparoscopic gastrectomy (LG) and robot-assisted gastrectomy (RG) for gastric cancer (GC) patients with a history of abdominal surgery (HAS). This is the first study in this field to identify complication-related factors and compare survival outcomes using propensity score matching (PSM) and a competing risk model (CRM). A retrospective cohort study was conducted on GC patients with HAS who underwent radical LG or RG. PSM was applied to achieve baseline balance. Univariate and multivariate regression analyses were performed to identify factors independently associated with complications. CRM adjusted by inverse probability of censoring weighting (IPCW) was used to analyze overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS) across different TNM stages. PSM with a 3:1 ratio ensured baseline balance while minimizing sample loss (LG n = 87, RG n = 29). RG was associated with a significantly longer surgery duration but a lower incidence of overall and Clavien-Dindo (CD) grade ≥ 2 complications. Multivariate analysis identified RG (OR, 95% CI: 0.02, 0.01-0.15), surgery duration (OR, 95% CI: 1.01, 1.00-1.01), and lymphadenectomy extent (OR, 95% CI: 2.81, 1.16-7.25) as independent factors associated with overall complications. Likewise, RG (OR, 95% CI: 0.06, 0.01-0.38), surgery duration (OR, 95% CI: 1.01, 1.00-1.02), and tumor size (OR, 95% CI: 1.02, 1.00-1.04) were independently associated with CD grade ≥ 2 complications. Kaplan-Meier analyses based on IPCW-adjusted CRM showed no significant differences in OS, CSS, and DFS between RG and LG across TNM stages. RG may efficiently reduce complications compared to LG but offers no survival benefit, suggesting a potential advantage in perioperative safety for GC patients with HAS.
尚无研究比较腹腔镜胃癌切除术(LG)与机器人辅助胃癌切除术(RG)对有腹部手术史(HAS)的胃癌(GC)患者的疗效。这是该领域第一项确定并发症相关因素并使用倾向评分匹配(PSM)和竞争风险模型(CRM)比较生存结果的研究。对接受根治性LG或RG的有HAS的GC患者进行了一项回顾性队列研究。应用PSM以实现基线平衡。进行单因素和多因素回归分析以确定与并发症独立相关的因素。采用逆概率删失加权(IPCW)调整的CRM分析不同TNM分期的总生存(OS)、癌症特异性生存(CSS)和无病生存(DFS)。3:1比例的PSM确保了基线平衡,同时将样本损失降至最低(LG n = 87,RG n = 29)。RG与显著更长的手术时间相关,但总体及Clavien-Dindo(CD)≥2级并发症的发生率较低。多因素分析确定RG(OR,95%CI:0.02,0.01 - 0.15)、手术时间(OR,95%CI:1.01,1.00 - 1.01)和淋巴结清扫范围(OR,95%CI:2.81,1.16 - 7.25)是与总体并发症独立相关的因素。同样,RG(OR,95%CI:0.06,0.01 - 0.38)、手术时间(OR,95%CI:1.01,1.00 - 1.02)和肿瘤大小(OR,95%CI:1.02,1.00 - 1.04)与CD≥2级并发症独立相关。基于IPCW调整后的CRM的Kaplan-Meier分析显示,RG和LG在不同TNM分期的OS、CSS和DFS方面无显著差异。与LG相比,RG可能有效降低并发症,但未提供生存获益,提示对有HAS的GC患者围手术期安全性有潜在优势。